🔎 Trials Near Me

Home › Disorders of Excessive Somnolence › Texas › Austin

Disorders of Excessive Somnolence clinical trials in Austin, TX

7 studies for Disorders of Excessive Somnolence are looking for participants at sites in and around Austin (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence

RecruitingPhase 2/3
  • Austin, Texas, Austin
Ages 18 to 70 · All sexes · Updated Oct 2, 2026 · NCT07598708

A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)

RecruitingPhase 3
  • Aayus Research, Austin
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT07500090

A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1

RecruitingPhase 3
  • Alkermes Investigational Site, Austin
Ages 18 to 70 · All sexes · Updated Sep 3, 2026 · NCT07455383

A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2

RecruitingPhase 3
  • Alkermes Investigational Site, Austin
Ages 18 to 70 · All sexes · Updated Sep 3, 2026 · NCT07502443

A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia

RecruitingPhase 2/3
  • Alkermes Investigational Site, Austin
Ages 18 to 70 · All sexes · Updated Aug 7, 2026 · NCT06767683

Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol

RecruitingPhase 3
  • Clinical Research Site, Austin
Ages 18 to 65 · All sexes · Updated Jul 24, 2026 · NCT07484217

A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia

RecruitingPhase 2
  • Austin, Texas, Austin
Ages 18 to 65 · All sexes · Updated Apr 16, 2026 · NCT07096674

Disorders of Excessive Somnolence trials in other cities

Other studies in Austin

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.